Key regions: Germany, Spain, Japan, United Kingdom, United States
The Medical Devices market in Israel has been experiencing steady growth in recent years, driven by a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Medical Devices market in Israel have been shifting towards more advanced and innovative products. Israeli consumers, like their counterparts worldwide, are increasingly seeking medical devices that offer improved functionality, convenience, and ease of use. They are also placing a greater emphasis on devices that are technologically advanced and offer better patient outcomes. This preference for advanced medical devices is driving the demand for products such as wearable devices, telemedicine devices, and minimally invasive surgical instruments. Trends in the market are also contributing to the growth of the Medical Devices market in Israel. One notable trend is the increasing adoption of digital health technologies. Israel has emerged as a global leader in digital health innovation, with a thriving ecosystem of startups and research institutions. This has led to the development of a wide range of digital health solutions, including remote patient monitoring devices, mobile health apps, and artificial intelligence-powered diagnostic tools. The growing adoption of these technologies is driving the demand for related medical devices in Israel. Another trend in the market is the growing focus on personalized medicine. Israeli healthcare providers and patients are increasingly recognizing the potential benefits of personalized treatment approaches, which take into account individual patient characteristics and genetic profiles. This has led to an increased demand for medical devices that enable personalized diagnostics, monitoring, and treatment. Examples include genetic testing devices, point-of-care diagnostic devices, and personalized drug delivery systems. Local special circumstances also play a role in the development of the Medical Devices market in Israel. The country has a highly skilled and innovative workforce, with a strong emphasis on research and development. This has fostered a culture of innovation and entrepreneurship in the medical devices sector, leading to the development of cutting-edge technologies and solutions. Additionally, Israel has a well-established healthcare system that provides universal coverage and access to medical devices, creating a favorable environment for market growth. Underlying macroeconomic factors are also contributing to the growth of the Medical Devices market in Israel. The country has a strong economy and a high level of healthcare expenditure, which supports the demand for medical devices. Furthermore, Israel has a rapidly aging population, which is driving the need for medical devices that cater to the healthcare needs of elderly individuals. This includes devices for chronic disease management, mobility aids, and assistive technologies. In conclusion, the Medical Devices market in Israel is experiencing steady growth due to customer preferences for advanced and innovative products, trends in the market such as the adoption of digital health technologies and personalized medicine, local special circumstances including a culture of innovation and a well-established healthcare system, and underlying macroeconomic factors such as a strong economy and an aging population. These factors are expected to continue driving the growth of the market in the coming years.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
